跳至主要内容
临床试验/NCT06581263
NCT06581263已完成不适用

Investigating the Use of Virtual Reality in Psychedelic Research or Clinical Practice

Yale University2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年7月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
Assess subjective experience of novel VRP (DeepDream) comparable to a standard dose of psychedelics.

研究概览

简要总结

The purpose of this study is to evaluate a novel VRP.

详细描述

The primary objective of this study is to determine whether the subjective experience of a novel VRP (DeepDream) will be comparable to a standard dose of psychedelics. This study also looks to compare the subjective experience of DeepDream VRP to other available VR modalities developed to mimic psychedelic subjective experience along with assessing the incidence of VRP adverse effects.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Other

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to provide informed consent
  • No history or current DSM-V diagnosis

排除标准

  • Unstable medical conditions

结局指标

主要结局

Assess subjective experience of novel VRP (DeepDream) comparable to a standard dose of psychedelics.

时间窗: Day 0 through Day 30

Subject experience will be assessed using the Altered States of Consciousness Rating Scale.

次要结局

  • Assess the incidence of VRP adverse effects, principally virtual reality sickness (VRS) and neck and upper back pain.(Day 0 through Day 30)

研究者

发起方
Yale University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anahita Bassir Nia

Assistant Professor of Psychiatry

Yale University

研究点 (2)

Loading locations...

相似试验